Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Arthur Chang is active.

Publication


Featured researches published by Arthur Chang.


The Lancet Global Health | 2017

Association of acute toxic encephalopathy with litchi consumption in an outbreak in Muzaffarpur, India, 2014: a case-control study.

Aakash Shrivastava; Anil Kumar; Jerry D. Thomas; Kayla F. Laserson; Gyan Bhushan; Melissa D. Carter; Mala Chhabra; Veena Mittal; Shashi Khare; James J. Sejvar; Mayank Dwivedi; Samantha L. Isenberg; Rudolph C. Johnson; James L. Pirkle; Jon D Sharer; Patricia L. Hall; Rajesh Yadav; Anoop Velayudhan; Mohan Papanna; Pankaj Singh; Somashekar D; Arghya Pradhan; Kapil Goel; Rajesh Pandey; Mohan Kumar; Satish Kumar; Amit Chakrabarti; Sivaperumal P; A Ramesh Kumar; Joshua G. Schier

BACKGROUND Outbreaks of unexplained illness frequently remain under-investigated. In India, outbreaks of an acute neurological illness with high mortality among children occur annually in Muzaffarpur, the countrys largest litchi cultivation region. In 2014, we aimed to investigate the cause and risk factors for this illness. METHODS In this hospital-based surveillance and nested age-matched case-control study, we did laboratory investigations to assess potential infectious and non-infectious causes of this acute neurological illness. Cases were children aged 15 years or younger who were admitted to two hospitals in Muzaffarpur with new-onset seizures or altered sensorium. Age-matched controls were residents of Muzaffarpur who were admitted to the same two hospitals for a non-neurologic illness within seven days of the date of admission of the case. Clinical specimens (blood, cerebrospinal fluid, and urine) and environmental specimens (litchis) were tested for evidence of infectious pathogens, pesticides, toxic metals, and other non-infectious causes, including presence of hypoglycin A or methylenecyclopropylglycine (MCPG), naturally-occurring fruit-based toxins that cause hypoglycaemia and metabolic derangement. Matched and unmatched (controlling for age) bivariate analyses were done and risk factors for illness were expressed as matched odds ratios and odds ratios (unmatched analyses). FINDINGS Between May 26, and July 17, 2014, 390 patients meeting the case definition were admitted to the two referral hospitals in Muzaffarpur, of whom 122 (31%) died. On admission, 204 (62%) of 327 had blood glucose concentration of 70 mg/dL or less. 104 cases were compared with 104 age-matched hospital controls. Litchi consumption (matched odds ratio [mOR] 9·6 [95% CI 3·6 - 24]) and absence of an evening meal (2·2 [1·2-4·3]) in the 24 h preceding illness onset were associated with illness. The absence of an evening meal significantly modified the effect of eating litchis on illness (odds ratio [OR] 7·8 [95% CI 3·3-18·8], without evening meal; OR 3·6 [1·1-11·1] with an evening meal). Tests for infectious agents and pesticides were negative. Metabolites of hypoglycin A, MCPG, or both were detected in 48 [66%] of 73 urine specimens from case-patients and none from 15 controls; 72 (90%) of 80 case-patient specimens had abnormal plasma acylcarnitine profiles, consistent with severe disruption of fatty acid metabolism. In 36 litchi arils tested from Muzaffarpur, hypoglycin A concentrations ranged from 12·4 μg/g to 152·0 μg/g and MCPG ranged from 44·9 μg/g to 220·0 μg/g. INTERPRETATION Our investigation suggests an outbreak of acute encephalopathy in Muzaffarpur associated with both hypoglycin A and MCPG toxicity. To prevent illness and reduce mortality in the region, we recommended minimising litchi consumption, ensuring receipt of an evening meal and implementing rapid glucose correction for suspected illness. A comprehensive investigative approach in Muzaffarpur led to timely public health recommendations, underscoring the importance of using systematic methods in other unexplained illness outbreaks. FUNDING US Centers for Disease Control and Prevention.


Drug Testing and Analysis | 2017

Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™ — United States, 2013

Kevin Chatham-Stephens; Ethel Taylor; Arthur Chang; Amy Peterson; Johnni H. Daniel; Colleen Martin; Patricia A. Deuster; Rebecca S. Noe; Stephanie Kieszak; Josh Schier; Karl C. Klontz; Lauren Lewis

In September 2013, the Hawaii Department of Health (HDOH) was notified of seven adults who developed acute hepatitis after taking OxyELITE Pro™, a weight loss and sports dietary supplement. CDC assisted HDOH with their investigation, then conducted case-finding outside of Hawaii with FDA and the Department of Defense (DoD). We defined cases as acute hepatitis of unknown etiology that occurred from April 1, 2013, through December 5, 2013, following exposure to a weight loss or muscle-building dietary supplement, such as OxyELITE Pro™. We conducted case-finding through multiple sources, including data from poison centers (National Poison Data System [NPDS]) and FDA MedWatch. We identified 40 case-patients in 23 states and two military bases with acute hepatitis of unknown etiology and exposure to a weight loss or muscle building dietary supplement. Of 35 case-patients who reported their race, 15 (42.9%) reported white and 9 (25.7%) reported Asian. Commonly reported symptoms included jaundice, fatigue, and dark urine. Twenty-five (62.5%) case-patients reported taking OxyELITE Pro™. Of these 25 patients, 17 of 22 (77.3%) with available data were hospitalized and 1 received a liver transplant. NPDS and FDA MedWatch each captured seven (17.5%) case-patients. Improving the ability to search surveillance systems like NPDS and FDA MedWatch for individual and grouped dietary supplements, as well as coordinating case-finding with DoD, may benefit ongoing surveillance efforts and future outbreak responses involving adverse health effects from dietary supplements. This investigation highlights opportunities and challenges in using multiple sources to identify cases of suspected supplement associated adverse events. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.


Disaster Medicine and Public Health Preparedness | 2018

Proposed “Exposure And Symptom Triage” (EAST) Tool to Assess Radiation Exposure After a Nuclear Detonation

John L. Hick; Judith L. Bader; C. Norman Coleman; Armin Ansari; Arthur Chang; Adela Salame-Alfie; Dan Hanfling; John F. Koerner

ABSTRACTOne of the biggest medical challenges after the detonation of a nuclear device will be implementing a strategy to assess the severity of radiation exposure among survivors and to triage them appropriately. Those found to be at significant risk for radiation injury can be prioritized to receive potentially lifesaving myeloid cytokines and to be evacuated to other communities with intact health care infrastructure prior to the onset of severe complications of bone marrow suppression. Currently, the most efficient and accessible triage method is the use of sequential complete blood counts to assess lymphocyte depletion kinetics that correlate with estimated whole-body dose radiation exposure. However, even this simple test will likely not be available initially on the scale required to assess the at-risk population. Additional variables such as geographic location of exposure, sheltering, and signs and symptoms may be useful for initial sorting. An interdisciplinary working group composed of federal, state, and local public health experts proposes an Exposure And Symptom Triage (EAST) tool combining estimates of exposure from maps with clinical assessments and single lymphocyte counts if available. The proposed tool may help sort survivors efficiently at assembly centers near the damage and fallout zones and enable rapid prioritization for appropriate treatment and transport. (Disaster Med Public Health Preparedness. 2018; 12: 386-395).


American Journal of Preventive Medicine | 2010

Transportation-Related Hazardous Materials Incidents and the Role of Poison Control Centers

Mark E. Sutter; Stephanie L. Hon; Arthur Chang; Michael D. Schwartz; D. Adam Algren; Joshua G. Schier; James Lando; Lauren Lewis

BACKGROUND Department of Transportation (DOT) mandates reporting of all serious hazardous materials incidents. Hazardous material exposures may result in secondary contamination of emergency departments, or delayed clinical effects. Poison control centers specialize in the management of patients exposed to toxic substances; however, poison control center notification is not required. PURPOSE The objective is to determine the frequency of poison control center notification after serious hazardous materials incidents when patients were transported to a hospital. METHODS A retrospective analysis was conducted of serious hazardous materials incidents as reported by DOT, matched with data from the American Association of Poison Control Centers from 2002 through 2006 that involved patient transport. Incidents were divided into four groups: those reported to a poison control center within 0-360 minutes of the incident; those reported within 361-1440 minutes of the incident; those reported within 1441-4320 minutes of the incident; and no poison control center notification. Analyses were performed on variables including date, time, substance, and time to notification. Data were received in January 2008. RESULTS One hundred fifty-four serious incidents met inclusion criteria. One hundred thirty-four incidents (87%) occurred without poison control center notification. Poison control centers were notified in 20 incidents (12.9%); 15 incidents (9.7%) were reported within 0-360 minutes of the incident (M=115 minutes, range=5-359 minutes); four incidents (2.6%) were reported within 361-1440 minutes of the incident (M=652 minutes, range=566-750 minutes); and one incident (0.7%) was reported after 4320 minutes following the incident. CONCLUSIONS Most serious hazardous materials incidents involving patient transport are not reported to poison control centers. Opportunities exist to increase utilization of poison control center resources without increasing financial burdens of the hazardous materials incident.


Morbidity and Mortality Weekly Report | 2017

Rapid Laboratory Identification of Neisseria meningitidis Serogroup C as the Cause of an Outbreak — Liberia, 2017

Jaymin C. Patel; Josiah S. George; Jeni Vuong; Caelin C. Potts; Catherine H. Bozio; Thomas A. Clark; Jerry D. Thomas; Joshua G. Schier; Arthur Chang; Jessica L. Waller; Maureen H. Diaz; Melissa Whaley; Laurel T. Jenkins; Serena Fuller; Desmond E. Williams; John T. Redd; Ray R. Arthur; Fahn Taweh; Yatta Vera Walker; Patrick Jowlehpah Hardy; Maxwell Freeman; Victoria Katawera; Gulu Gwesa; Miatta Zenabu Gbanya; Peter Clement; Henry Kohar; Mardia Stone; Mosoka Fallah; Tolbert Nyenswah; Jonas M. Winchell

On April 25, 2017, a cluster of unexplained illness and deaths among persons who had attended a funeral during April 21-22 was reported in Sinoe County, Liberia (1). Using a broad initial case definition, 31 cases were identified, including 13 (42%) deaths. Twenty-seven cases were from Sinoe County (1), and two cases each were from Grand Bassa and Monsterrado counties, respectively. On May 5, 2017, initial multipathogen testing of specimens from four fatal cases using the Taqman Array Card (TAC) assay identified Neisseria meningitidis in all specimens. Subsequent testing using direct real-time polymerase chain reaction (PCR) confirmed N. meningitidis in 14 (58%) of 24 patients with available specimens and identified N. meningitidis serogroup C (NmC) in 13 (54%) patients. N. meningitidis was detected in specimens from 11 of the 13 patients who died; no specimens were available from the other two fatal cases. On May 16, 2017, the National Public Health Institute of Liberia and the Ministry of Health of Liberia issued a press release confirming serogroup C meningococcal disease as the cause of this outbreak in Liberia.


Online Journal of Public Health Informatics | 2016

Increase in Adverse Health Effects Related to Synthetic Cannabinoid Use

Royal Law; Josh Schier; Colleen Martin; Arthur Chang; Amy Wolkin; Jay Schauben

Introduction Synthetic cannabinoids include various psychoactive chemicals that are sprayed onto plant material, which is then smoked or ingested to achieve a “high.” These products are sold under a variety of names (e.g., synthetic marijuana, spice, K2, black mamba, and crazy clown) and are sold in retail outlets as herbal products and are often labeled not for human consumption. Law enforcement agencies regulate many of these substances; however, manufacturers may frequently change the formulation and mask their intended purpose to avoid detection and regulation. On April 6, 2015, automated surveillance algorithms via surveillance through the National Poison Data System (NPDS), a web-based surveillance system of all calls to United States (US) poison centers (PCs), identified an increase in calls to PCs related to synthetic cannabinoid use. To identify risk factors and adverse health effects, CDC analyzed all calls to PCs about synthetic cannabinoid use from January to May, 2015.


Journal of Medical Toxicology | 2014

On the Role of Poison Centers in Radiation Emergency Preparedness and Response Activities: Findings of the "Radiation Emergencies Public Health Roundtable" (Atlanta, GA—August 2012)

Adam C. Pomerleau; J. L. Schauben; A. C. Bronstein; Arthur Chang

After the earthquake and tsunami that struck Japan on 11 March 2011, the ensuing Japanese nuclear power plant emergency renewed concerns among officials and citizens of the USA about contamination with radioactive material and the need for medical countermeasures (MCMs) to protect the publics health. The nations poison centers (PCs), particularly those on the West Coast, received 400 calls requesting information about protective actions for contamination with radioactive material and exposure to ionizing radiation. Centers for Disease Control and Prevention (CDC) experts analyzed PC call data through the National Poison Data System (NPDS) in order to target communication messages effectively [1]. Poison centers are already used extensively by medical facilities, individual clinicians, and the general public to assess, triage, manage, and monitor known or suspected toxic exposures. Collectively, PCs receive more than four million exposure and information calls annually [2]. All calls are electronically reported to NPDS, a near real-time surveillance system maintained by the American Association of Poison Control Centers (AAPCC) and CDC. As noted by CDC speakers at a March 2010 Public Health Grand Rounds session, there is a lack of sufficient radiation subject matter expertise, as well as a lack of education and training, in this topic within the public health community [3]. These shortcomings also apply to PC staff. Calls about radiation are not as frequent as calls about other topics; therefore, PC staff may lack sufficient knowledge of such topics as ionizing radiation, the health effects of radiation exposure, contamination with radioactive materials, and appropriate MCMs to treat each type of incident. The Health Studies Branch and Radiation Studies Branch are located within CDCs National Center for Environmental Health in Atlanta, Georgia. Staff from these two branches proposed to identify and discuss the existing knowledge gaps in radiation emergency preparedness and response among PC staff by organizing an educational session for PC professionals, followed by a roundtable discussion. Organizers envisioned the roundtable as a means of initiating a continuing dialogue between PCs and other public health entities about the current and potential roles that PCs can play during a radiation public health emergency. This paper briefly summarizes the roundtable and its main findings; a full report is available online at CDCs radiation emergencies Web portal.1


Morbidity and Mortality Weekly Report | 2015

Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015

Royal Law; Josh Schier; Colleen Martin; Arthur Chang; Amy Wolkin


Drug Testing and Analysis | 2016

Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ — Hawaii, 2013

David Johnston; Arthur Chang; Melissa Viray; Kevin Chatham-Stephens; Hua He; Ethel Taylor; Linda L. Wong; Joshua G. Schier; Colleen Martin; Daniel Fabricant; Monique Salter; Lauren Lewis; Sarah Y. Park


Journal of Clinical Toxicology | 2012

Characterization of Animal Exposure Calls Captured by the National Poison Data System, 2000-2010

Danielle E. Buttke; Joshua G. Schier; Alvin C. Bronstein; Arthur Chang

Collaboration


Dive into the Arthur Chang's collaboration.

Top Co-Authors

Avatar

Colleen Martin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Joshua G. Schier

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Lauren Lewis

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Amy Wolkin

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Josh Schier

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Alvin C. Bronstein

University of Colorado Denver

View shared research outputs
Top Co-Authors

Avatar

Carl Skinner

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jerry D. Thomas

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Adela Salame-Alfie

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Armin Ansari

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge